In individuals with obesity and cardiometabolic disorders, low irisin levels might be considered proarrhythmia markers, as obesity disrupts the balance in the adipose tissue and the endocrine function of the muscle tissue. Here, FNDC5 is linked to obesity due to melanocortin 4 receptor deficiency.